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Abstract
Organisms exposed to oxidative stress respond by orchestrating a stress response to prevent further damage. Intracellular
levels of antioxidant agents increase, and damaged components are removed by autophagy induction. The KEAP1-NRF2
signaling pathway is the main pathway responsible for cell defense against oxidative stress and for maintaining the cellular
redox balance at physiological levels. Sulforaphane, an isothiocyanate derived from cruciferous vegetables, is a potent
inducer of KEAP1-NRF2 signaling and antioxidant response element driven gene expression. In this study, we show that
sulforaphane enhances the expression of the transcriptional coregulator SPBP. The expression curve peaks 6–8 hours post
stimulation, and parallels the sulforaphane-induced expression of NRF2 and the autophagy receptor protein p62/SQSTM1.
Reporter gene assays show that SPBP stimulates the expression of p62/SQSTM1 via ARE elements in the promoter region,
and siRNA mediated knock down of SPBP significantly decreases the expression of p62/SQSTM1 and the formation of p62/
SQSTM1 bodies in HeLa cells. Furthermore, SPBP siRNA reduces the sulforaphane induced expression of NRF2, and the
expression of the autophagy marker protein LC3B. Both these proteins contain ARE-like elements in their promoter regions.
Over-expressed SPBP and NRF2 acts synergistically on the p62/SQSTM1 promoter and colocalize in nuclear speckles in HeLa
cells. Collectively, these results suggest that SPBP is a coactivator of NRF2, and hence may be important for securing
enhanced and sustained expression of NRF2 induced genes such as proteins involved in selective autophagy.
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Introduction
Oxidative stress causes damage to multiple cellular molecules,
and is a major contributing factor in a variety of human diseases
such as cancer, neurodegenerative disorders, inflammatory
diseases, cardiovascular disease and ageing [1]. Cells have
developed a defence system, a variety of antioxidant enzymes
and molecules, to detoxify oxidative species. The transcription
factor NRF2 (nuclear factor erythroid 2-related factor) is a master
regulator of response to oxidative stress, regulating the basal and
inducible expression of many antioxidant pathway genes contain-
ing antioxidant response elements (AREs) in their transcription
control region (reviewed in [1,2]). NRF2 knock-out mice display
increased sensitivity to a number of xenobiotics, thus highlighting
the importance of NRF2 in cellular stress responses (reviewed in
[3,4]). In unstressed conditions, the Cullin3-adaptor protein
KEAP1 constitutively targets NRF2 for ubiquitin conjugation
and degradation by the proteasome. Post-translational modifica-
tion of KEAP1 and NRF2 by electrophiles and oxidants impairs
the interaction between KEAP1 and NRF2, resulting in stabili-
sation and rapid accumulation of NRF2 in the nucleus [1,5]. Here,
NRF2 transactivates the antioxidant response element (ARE)
present in the promoter region of many antioxidant genes.
Constitutively activated NRF2 promotes longevity and confers
increased tolerance to oxidative stress in model organisms [6,7].
Sulforaphane, a naturally occurring isothiocyanate derived from
cruciferous vegetables, stimulates induction of enzymes involved in
xenobiotic metabolism [8,9] and proteasome subunit levels via an
NRF2-dependent mechanism [10].
Autophagy is an essential cellular mechanism of adaption to
external or internal stress. It includes degradation of intracellular
components during starvation conditions, elimination of aggre-
gated proteins, turnover of damaged or old organelles, and
protection against invading microorganisms (reviewed in [11]).
Autophagy can mediate cardioprotection and neuroprotection,
delay the pathogenic manifestations of ageing and prolong life
span (reviewed in [12]). The autophagic process is initiated by
formation of a double membrane structure, the autophagosome,
that grows and isolates a part of the cytosol. The autophagosome
matures and fuses with a lysosome, leading to degradation of the
autophagosomal contents. An essential step in autophagy is the
conjugation of phosphatidylethanolamine to microtubule-associ-
ated protein 1 light-chain 3 (LC3). This converts the soluble form
of LC3 (LC3 I) to the LC3 II form that specifically associates with
autophagosomes [13–15]. p62/SQSTM1 (hereafter termed p62)
acts as a receptor for selective autophagy, recognising the LC3 II
protein in the autophagic membrane and ubiquitin molecules
attached to the autophagic substrate determined for degradation
[16,17]. Accumulation of p62 very often reflects a transient or
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constitutive inhibition of autophagy. Brain-specific block in
autophagy in mice causes rapid development of neurodegenera-
tion accompanied by accumulation of p62 in ubiquitinated protein
inclusions [18,19]. In the heart, cardiac-specific deficiency in
autophagy causes myopathy and contractile dysfunction accom-
panied by accumulation of ubiquitin and p62 [20]. Increased
levels of p62 correlate with aggressive breast cancer [21] and
prostate cancer [22], and a study suggests that accumulation of
p62 may have a strong tumor promoting effect [23]. p62 is also a
scaffold protein for cell survival and death signalling pathways,
and it is assumed that accumulation of p62 leads to dysregulated
activation of these signalling pathways (reviewed in [24]). Stress
signals generated in cells during inflammation, protein misfolding
and aggregation, oxygen and UVA exposure, or exposure to drugs
like arsenic, resveratrol, PMA and valproic acid, are shown to
induce p62 transcription. Conversely, p62 expression is found to
be down-regulated when cells are exposed to amino acid
starvation and hypoxia-activated autophagy. Recently it was
shown that sulforaphane induces p62 expression in an NRF2
dependent manner. NRF2 binds to an ARE element in the p62
promoter and in this way enhances p62 expression. p62, on the
other hand, competes with NRF2 for KEAP1 binding leading to
NRF2 stabilisation and accumulation. In this manner p62
generates a positive feedback loop contributing to prolonged
activation of NRF2 in response to oxidative stress [25].
The transcriptional coregulator SPBP (also named TCF20) is a
220 kDa multidomain nuclear protein expressed in most cells and
tissues (Figure 1A) [26,27]. SPBP was originally identified as a
platelet-derived-growth-factor (PDGF) induced protein involved in
transcriptional activation of the matrix metalloprotease-3 (MMP3)
promoter [28]. This activation was later found to be dependent on
Ets1 binding to the MMP3 promoter [27]. SPBP is also reported
to enhance the transcription potential of Sp1 and c-Jun [26],
androgen receptor [29], and SNURF/RNF4 [30]. SPBP associ-
ates strongly with nucleosomes via two separate nucleosome
binding domains [31]. One is the C-terminal cysteine rich region
with similarity to an extended Plant Homeo Domain/ATRX-
DNMT3L-DNMT3A domain (ePHD/ADD)(Figure 1A) and the
other is a novel domain localized adjacent to the DNA binding
domain with a conserved AT-hook motif [26]. The ePHD/ADD
domain is also involved in protein-protein interactions [27]. In the
cell nucleus, SPBP displays relatively low mobility and is enriched
in chromatin dense regions, clearly indicating that it is a chromatin
binding protein [31].
Here we have shown that expression of the transcriptional
coregulator and chromatin binding protein SPBP is induced by
sulforaphane. Sulforaphane is a potent inducer of ARE-driven
gene expression via KEAP1-NRF2 signalling. The autophagic
receptor and signalling scaffold protein p62 contains conserved
ARE elements in its promoter region, and we found that SPBP
enhances p62 expression via these elements. SPBP associated with
the p62 promoter, and siRNA mediated knock down of SPBP
significantly downregulated p62 expression and formation of p62
bodies in HeLa cells. Furthermore, knock down of SPBP affected
expression of LC3B, and the sulforaphane induced expression of
NRF2. NRF2 regulates its own expression via ARE elements in its
promoter region, and an ARE-like element is also present in the
LC3B promoter. Hence, SPBP acts as a transcriptional coactivator
of NRF2, and may be important for enhanced and sustained
cellular response to oxidative stress mediated by KEAP1-NRF2
signalling, including the NRF2 mediated induction of proteins
involved in selective autophagy.
Materials and Methods
Plasmid Constructs
cDNA constructs were subcloned into Gateway entry vectors
and expression clones made as described (Invitrogen). All
constructs were verified by DNA sequencing. Human NRF2 was




CATCTGGC -39 and image clone IRAUp969G0565D as
template, and recombined into pDONR221 (Invitrogen). The
21781/+46 p62 promoter construct, the 21781/+46 construct
with a mutated ARE site at position 21300, and the NQO1
promoter constructs are described previously [25]. The ARE site
at position 2330 was mutated using primer 59-CAACTGAGGA-
TATTGCAGGGACATGGCCAGGCCCAAGC-3, and the AP1
binding site was mutated using primer 59-CGGGCTCGA-
GATCTCTCTGTCACTGCCGCCAGACC-39. All mutation
constructs were generated by PCR using Pfu Turbo polymerase
(STRATAGENE) and verified by DNA sequencing with BigDye
v3.1 (Applied Biosystems). The SPBP constructs are described
previously [27]. The TpT and 601 nucleosome position sequences,
and the Control sequence, were amplified by PCR using primers
59-CGCGAAGCTTCTCCTGCAGACGCGTCGGTGTTA-
GAGCC-39 and 59-CGCGCTGCAGTCTAAGCTT-
GAATTCTCTAGACAGTGTCCC-39 for TpT, 59-
CGCGAAGCTTCTCCTGCAGCCTGGA-
GAATCCCGGTGCCG-39 and 59-CGCGCTGCAGTC-
TAAGCTTCACAGGATGTATATATCTGAC-39 for 601, and
59-CGCGAAGCTTCTCCTGCAGTAAAAGATGCTGAA-
GATC-39 and 59-CGCGCTGCAGTCTAAGCTTATAA-
TACCGCGCCACATAGC9 for Control. Plasmids pTpT and
p601, kind gifts from R. Kingston’s group, were used as template.
The PCR products were digested by HindIII, inserted into the
HindIII sites of the p62 and NQO1 promoter constructs, and
verified by DNA sequencing.
Cell Culture
HeLa (ATCC CCL2) and HEK293 (ATCC CRL-1573) cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM).
U2OS-TA cells [27] were maintained in DMEM with 400 mg/ml
geneticin (G418, SIGMA) and puromycin dihydrochloride (1 mg/
ml). In addition, the media for all cell lines were supplemented
with 10% fetal bovine serum (Biochrom AG, S0615) and 1%
streptomycin-penicillin (Sigma, P4333). Cultured cells were
maintained at 37uC with 95% air and 5% CO2 in a humidified
atmosphere.
Cells were amino acid starved in Hanks Balanced Salts medium
(HBSS)(H137, SIGMA) for 2 hours before treatment for 4 hours
with the following pharmacological agents Bafilomycin A1
(0.2 mM), Sulforaphane (20 mM), or MG132 (0.2 mM).
Antibodies and Reagents
The following primary antibodies were used: Rabbit anti-SPBP
antibody [27], monoclonal anti-p62 antibody (BD Transduction
Laboratories), rabbit anti-NRF2 antibody (Santa Cruz, SC-13032,
Abcam ab62352), rabbit anti-LC3B antibody (SIGMA, L7543),
rabbit anti-KEAP1 antibody (ProteinTech, 10503-2-AP), mouse
anti-Flag antibody (Stratagene, 200471), rabbit anti-actin anti-
bodies (Sigma, A 2066). Secondary antibodies used were: HRP-
conjugated goat anti-rabbit IgG and anti-mouse IgG antibodies
(BD Bioscience Pharmingen). AlexaFluor 568 and AlexaFluor 548
conjugated goat anti mouse and anti-rabbit IgG (Molecular
SPBP Acts as a Coactivator of NRF2
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Probes). Sulforaphane (S 4441), Bafilomycin A1 (B 1793) and MG
132 (C 2211) were purchased from Sigma-Aldrich.
Western Blotting with total cell extracts
Western Blotting using total cell extracts were performed
essentially as described previously [25]. For siRNA knock-down,
the cells were transfected with 20 nM of each siRNA using
RNAiMAX (Invitrogen). The SPBP, p62 and Control siRNAs are
described previously [25,27]. The cells were harvested 48–
72 hours post transfection. Sulforaphane, Bafilomycin A1 and
MG 132 treatments were as indicated in each figure. Quantitation
of bands were performed using the LumiAnalystTM Image
Analysis Software, and all bands were correlated to actin blotted
on the same membrane.
Reporter gene assays
Subconfluent HEK293 cells in 24-well tissue culture dishes
(Becton Dickinson) were transiently transfected using Metafectene
Pro (Biontex) according to the manufacturer’s protocol. All wells
were cotransfected with 60 ng of luciferase reporter vectors,
100 ng or as indicated in the figures of SPBP expression vector
(pDEST-HA-SPBP), 100 ng of CBP expression vector (pHA-
CBP), 50 ng or as indicated in the figure of pDEST-HA-NRF2
and 5 ng of a b-galactosidase expression vector. pcDNA3HA
(Invitrogen) was used to equalize the concentration of DNA in
each transfection. Extracts were prepared 20 hours post transfec-
tion and analyzed essentially as described previously [27]. All
assays were performed in triplicates and repeated at least three
times.
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation was performed mainly as
described [27]. 1.56107 HeLa cells were used for each tested
condition. Crosslinking with 1% formaldehyde was carried out for
10 minutes at 25uC. This was stopped by adding 0.125 M glycine
for 5 minutes, 25uC. Harvested cells were resuspended in 500 ml
Lysis Buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1,
protease inhibitor cocktail), and incubated 10 minutes on ice
before sonication 20 minutes in a Bioruptor (Diagenode). The
DNA fragments were purified using a QIAquick Spin Kit
(QIAGEN). One to five ml from a 30 ml DNA extraction were
used for 35 cycles of PCR amplification. PCR primers used to
amplify the p62 promoter and the Cathepsin D promoter were as
described [25].
Real-Time PCR
Subconfluent HeLa cells in 6 well dishes were transfected with
20 nM SPBP siRNA or scrambled siRNA [27] using RNAiMAX
(Invitrogen). 48–72 hours later RNA was isolated using RNAeasy
Plus Minikit (QIAGEN), cDNA made using Transcriptor Univer-
Figure 1. Sulforaphane enhances SPBP expression. (A) Schematic representation of the domain structure of human SPBP. TAD: trans-
activation domain, DBD: DNA binding domain, NLS: Nuclear Localisation Signal, ePHD/ADD: extended PHD/ADD domain, Q1/Q2: Glutamine rich
stretches. Numbers below indicate amino acid positions. (B) NRF2, SPBP and p62 display similar induction upon sulforaphane treatment. HeLa cells
were exposed to 20 mM sulforaphane and cell extracts harvested for the indicated time points. Equivalent aliquots from the extracts were subjected
to SDS-PAGE and western blot using specific anti-SPBP antibody, anti-p62 antibody, anti-NRF2 antibody or anti-actin as indicated. Fold induction
calculated and correlated to actin in three independent experiments with standard deviations are shown to the right (**p,0.01, *p,0.05). (C) Control
experiment showing that DMSO alone does not induce any changes in NRF2, SPBP or p62 expression levels. Equivalent aliquots of HeLa cell extracts
exposed to DMSO and harvested for the indicated time points were subjected to SDS-PAGE and western blot using specific anti-SPBP antibody, anti-
p62 antibody, anti-NRF2 antibody or anti-actin antibody as indicated. Fold induction calculated and correlated to actin are shown to the right.
doi:10.1371/journal.pone.0085262.g001
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sal cDNA Master (Roche), and RT-PCR performed on a
STRATAGENE x 300 amplification system using FastStart




ATAGGAGCGAGGGCA-39; and GADPH: 59-TGGGTGTGA-
ACCACGAGAA-39 and 59-GGCATGGACTGTGGTCATGA-
39. The reactions were run for an initial step at 95uC for 10 min,
followed by 40 cycles of amplification at 95uC for 15 s and 60uC
for 1 min. All data were collected during the extension step, and a
melting curve was obtained at the end of the PCR reaction to
verify that only one product was produced. The calculations were
carried out using Delta-delta CT method.
Confocal microscopy
HeLa cells were cultured in 8-chambered cover slides (Nunc)
and transiently transfected with 20 nM siRNA, or 50 ng
pDestEGFP-NRF2 and 150 ng pDestCherry-SPBP using Tran-
sIT-LT1 (Mirus Bio) according to the manufacturer’s protocol.
Live cell images were taken one day post transfection using a Leica
SP5 or a LSM510-META confocal laser scanning microscope. For
quantification of p62 bodies, siRNA transfected cells were fixed in
4% paraformaldehyde 2 days post transfection. The cells were
permeabilised by 0.1% Triton X-100, for 5 min at room
temperature. Staining with antibodies was as described previously
[32]. Images were obtained using a LSM510-META confocal
microscope and p62 bodies were counted manually. Pearson’s
colocalisation coefficient and scatter were generated using Volocity
(Perkin Elmer). Images were processed using Canvas version 11
(ACD systems).
Coimmunoprecipitation
Subconfluent HeLa cells in 10 cm dishes (Nunc) were
transiently co-transfected with either pDestEGFP-NRF2 and
pDESTMyc-SPBP, or pDEST-EGFP and pDESTMyc-SPBP
using Metafectene Pro (Biontex) according to the manufacturer’s
protocol. The cells were harvested 20 hours post transfection and
co-immunoprecipitation performed using Chromotek-GFP-Trap
(Allele) according to the manufacturer’s protocol.
Figure 2. SPBP mediates transcriptional activation via ARE
elements. (A) Schematic representation of the human 21781/+46 p62
promoter construct in front of the Luciferase gene. Conserved
transcription factor binding sites relevant for this study are indicated.
(B) Mutation of the ARE elements impairs SPBP mediated activation of
the p62 promoter. Transient transfections were carried out in HEK293
cells using 60 ng of wild-type or mutated reporter vectors, and 100 ng
of expression vectors for SPBP (upper panel) or CBP (lower panel). The
data represent the mean of three independent experiments with
standard deviations, each performed in triplicate (**p,0.01, *p,0.05,
n.s. not significant). (C) Chromatin immunoprecipitations show that
SPBP is associated with the p62 promoter. HeLa cell extracts (1.56107
cells per antibody) were immunoprecipitated with preimmune serum,
polyclonal anti-SPBP antibody or polyclonal anti-NRF2 antibody. Input
Control (1:40) was included. PCR was performed on chromatin
precipitated with each antibody using primers aligning to positions
21324/21173 in the p62 promoter (upper panel). Primers aligning to
positions 23351/23069 of the cathepsin D promoter were used as
control. (D) SPBP mediated enhancement of the NQO1 promoter is
dependent on the ARE element. Transient transfections were carried
out in HEK293 cells using 60 ng of wild-type or mutated reporter
vectors, and 100 ng of SPBP expression vectors. The data shows the
mean of three independent experiments with standard deviations, each
performed in triplicate (**p,0.01, n.s. not significant).
doi:10.1371/journal.pone.0085262.g002
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Statistical analysis
Data were processed in Excel (Microsoft Corporation) to
generate bar charts and perform statistical analyses. Student’s t-
test was performed for each dependent variable. *: p, = 0.05 was
considered statistically significant, and **: p, = 0.01, very
significant. p.0.05 was considered not significant (n.s.)
Results
SPBP expression is enhanced in parallel to NRF2 and p62
upon sulforaphane treatment
SPBP was originally described as a transcription factor induced
when serum-starved NIH3T3 fibroblast cells were stimulated by
PDGF or serum [28]. Since then, we and others have found SPBP
to act as a transcriptional coactivator on several promoters [26–
30], but also as a transcriptional corepressor [33]. In an attempt to
identify the biological function of SPBP, we analyzed whether the
expression level of SPBP was regulated due to specific cellular
stimuli or stressors. Interestingly, we found that SPBP expression is
induced upon sulforaphane treatment of HeLa cells (Figure 1B).
Sulforaphane activates the redox sensitive transcription factor
NRF2 inducing expression of detoxifying phase-II enzymes, such
as quinone reductase and glutathione S-transferase, and has an
inhibitory effect on histone deacetylase activity [8]. The
sulforaphane induced SPBP expression increased and reached a
peak level around 8 hours post sulforaphane treatment (Figure 1B).
This expression pattern parallels the sulforaphane induction of
NRF2 and of the NRF2 regulated selective autophagy receptor
and signaling scaffold protein p62 (Figure 1B). DMSO alone did
not affect the expression levels of SPBP, p62 and NRF2
(Figure 1C), clearly indicating that the enhanced expression of
SPBP is a sulforaphane induced cellular response.
SPBP enhances p62 promoter activity via ARE elements
We have shown that sulforaphane induced expression of p62 is
mediated by NRF2 binding to a conserved ARE element at
position 21305/21293 in the p62 promoter [25]. The similar
sulforaphane induced expression of SPBP, NRF2 and p62,
together with the transcriptional coactivator function of SPBP,
prompted us to investigate whether SPBP could affect p62
promoter activity. Luciferase reporter gene assays using the p62
(21781/+46) promoter [25] in front of the luciferase gene
displayed a 2-fold induction of the p62 promoter mediated by
SPBP over-expression (Figure 2B). The well characterized
coactivator CBP enhanced p62 promoter activity 5-fold. CBP is
shown to acetylate NRF2 as an antioxidant response, augmenting
NRF2 DNA binding activity and also transcriptional activity [34].
To determine whether SPBP mediates its effect on the p62
promoter via NRF2, point mutations were introduced into two
conserved ARE elements in the promoter, the previously reported
NRF2 binding site at position 21305/21293 and an additional
conserved ARE element at position 2330 which, according to
ENCODE (http://genome.ucsc.edu), is found to be associated
with NRF2 (Figure 2A). Mutation of the ARE element at 2330
had significant impact on the basal p62 promoter activity (data not
shown), suggesting that this ARE element is important for basal
p62 promoter activity, while the 21330 site is the major site for
sulforaphane mediated induction of the promoter [25]. In another
p62 promoter construct, mutations were introduced into the AP1
binding site at position 21750 previously shown to be involved in
NF-kB mediated expression of p62 [35]. Reporter gene assays
showed that mutations of the ARE elements abolished the SPBP
mediated induction of the p62 promoter (Figure 2B), while the
CBP mediated activation seemed to be unaffected indicating that
CBP may act on the p62 promoter via other transcription factor
binding sites. This is in line with reports describing CBP as a
coactivator of numerous transcription factors (reviewed in [36]).
Chromatin immunoprecipitations were performed to evaluate
whether endogenous SPBP was associated with the p62 promoter.
Results presented in Figure 2C show that SPBP is associated with
the p62 promoter. To further confirm that SPBP may mediate
promoter activation via ARE sites, wild-type and ARE-mutated
constructs of the NRF2 target gene promoter NQO1 were
subjected to reporter gene assays with SPBP over-expression.
SPBP induced a modest but significant 1.4 fold induction of the
wild-type NQO1 promoter, while no induction of the ARE
mutated NQO1 construct were observed (Figure 2D). These
results clearly suggest that SPBP is able to enhance promoter
activity mediated via ARE elements.
Knock-down of SPBP impairs p62 expression and
formation of p62 bodies
SPBP and p62 is coexpressed in most human cells (Figure 3A)
and tissues (www.proteinatlas.org). However, there is no clear
correlation of their expression levels. To investigate whether SPBP
may impact on the p62 expression levels in cells, siRNA mediated
knock-down of SPBP was introduced into HeLa cells. Knock-
down of SPBP using two different SPBP siRNAs [27] reproducibly
decreased the amount of p62 (Figure 3B). Quantitative real-time
PCR of p62 mRNA isolated from the SPBP siRNA treated HeLa
cells showed a p62 mRNA reduction similar to the reduction of the
p62 protein, indicating that SPBP affects p62 transcription
(Figure 3C). This correlates well with our data showing that
SPBP enhances p62 transcription via ARE elements in the p62
promoter. The p62 protein is both a scaffold protein in signalling
pathways and a cargo receptor for selective autophagy (reviewed
in [11,37]).When cells are exposed to oxidative stress, the amount
of p62-containing cytoplasmic bodies increases. Here we wanted
to determine whether SPBP could have an effect on the stress-
induced formation of p62 bodies. HeLa cells subjected to SPBP
siRNA or Conrol siRNA, and sulforaphane were stained with
antibodies against SPBP and p62. The images in Figure 3D (upper
panel) show that sulforaphane stimulated HeLa cells display
relatively high p62 expression levels forming distinct round p62
bodies in addition to a diffuse cytoplasmic distribution. Knock
down of SPBP clearly impaired the formation of p62 bodies and
diminished the cytoplasmic p62 staining (Figure 3D, lower panel).
Quantitation of p62 bodies showed that knock down of SPBP by
siRNA clearly reduced the formation of p62 bodies in sulforaph-
ane treated cells compared to control siRNA (Figure 3D, right
graph). Collectively these results suggest that SPBP plays a role in
the p62 mediated oxidative stress response.
SPBP does not enhance NRF2 mediated transcription by
facilitating nucleosome traversal
SPBP contains two nucleosome binding domains and displays
strong affinity for nucleosomes [31]. Nucleosomes pose a barrier to
RNA polymerase II, thus transcription through chromatin require
the concerted action of transcriptional coactivators including
ATP-dependent remodeling machines, histone modification en-
zymes and histone chaperones (reviewed in [38]). The ATP-
dependent remodeling enzyme SWI/SNF travels with RNA
polymerase II and evicts histones on active genes [39], and it is
shown that the transcriptional coactivator and SWI-SNF chro-
matin-remodeling-complex protein BRG1 is recruited to posi-
tioned nucleosomes and facilitate RNA polymerase II traversal of
nucleosomes during transcriptional elongation [40]. Knock-down
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Figure 3. Knock down of SPBP impairs p62 expression and sulforaphane induced p62 body formation. (A) Endogenous SPBP and p62
are coexpressed in several cell lines. Extracts of the indicated human cell lines were analysed by western blotting using the indicated antibodies. (B)
siRNA mediated knock down of SPBP reduces p62 expression level. HeLa cells transfected with two various SPBP siRNAs were analysed by western
blotting using antibodies as indicated (left panel). The graph (right panel) shows the fold reduction calculated and correlated to actin in three
independent experiments with standard deviations (*p,0.05, n.s. not significant). (C) Knock down of SPBP reduces the amount of p62 mRNA
transcripts. The p62 mRNA levels were measured by quantitative RT-PCR. Hela cells were transfected with SPBP siRNAs or Control siRNA. RT-PCR
reactions were run on p62, GADPH and b-actin mRNA. The average amount of p62 mRNA correlated to b-actin and GADPH mRNA based on two
independent experiments are shown with standard deviations (*p,0.05, n.s. not significant). (D) p62 body formation upon sulforaphane treatment is
reduced in SPBP siRNA knock down cells. HeLa cells were transfected with SPBP siRNA or Control siRNA and treated with 20 mM sulforaphane for
8 hours two days post transfection. Cells were fixed, stained with polyclonal antibodies against SPBP (green) and p62 (red) and analysed by confocal
microscopy. The graph shows counting of p62 bodies in cells, each based on counting of more than 60 cells. Arrowheads indicate some of the p62
bodies in the cytoplasm.
doi:10.1371/journal.pone.0085262.g003
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of SWI/SNF by RNAi resulted in pausing of polymerase II at an
artificial introduced 601 nucleosome positioning sequence. In
order to investigate whether SPBP acted on the p62 promoter by
facilitating transcription through positioned nucleosomes, we
introduced two synthetically nucleosome positioning sequences
into the p62 promoter-luciferase construct (Figure 4). The 601
DNA sequence [41] has a stronger tendency to form nucleosomes
than the TpT sequence [42,43]. As control, 147 base pairs of a
prokaryotic ampicillin resistance gene was inserted in the same
position as the nucleosome forming sequences [40]. Luciferase
reporter gene assays showed that SPBP mediated enhancement of
transcription initiated on the p62 promoter was slightly impaired
by both the TpT and the 601 nucleosome positioning sequences
(Figure 4 and Figure S1A). The NRF2 mediated activation of the
p62 promoter was inhibited similarly (Figure 4 and Figure S1A).
Importantly, the synergism of SPBP and NRF2 was clearly
abolished by inserted nucleosome positioning sequences (Figure 4).
These results suggest that nucleosome traversal during transcrip-
tional elongation is not significantly facilitated by SPBP. Similar
results were obtained using the NRF2 regulated promoter NQO1
with inserted nucleosome positioning sequences downstream of the
transcriptional initiation site (Figure S1B). Both the SPBP and the
NRF2 mediated transcriptional activation of the NQO1 promoter
was inhibited by inserted nucleosome position sequences. Hence,
SPBP seems to exert its coactivation function via another
mechanism than facilitating RNA polymerase II traversal through
a nucleosome barrier.
SPBP is not an autophagy substrate
We have established an U2OS cell line stably over-expressing
EGFP-SPBP [27]. Western blot on cell extracts from these cells
shows that there is a significant 1.4 fold enhancement of p62
protein expression in U2OS cells overexpressing EGFP-SPBP
compared to cells overexpressing EGFP only (Figure 5A). Since
p62 is both an autophagic receptor and an autophagic substrate,
the increased level of p62 could be due to inhibited degradation by
autophagy. However, western blot of the autophagic marker
protein LC3B did not show any reduced formation of LC3B II in
these cells (Figure 5A). Furthermore, treatment of the cells with the
drug Bafilomycin A1 resulted in increased protein levels of p62
and LC3B II, indicating that p62 is degraded normally by
autophagy in the stably transfected U2OS cells (Figure S2A).
Bafilomycin A1 acts as an autophagy inhibitor as it prevents
maturation of autophagic vacuoles by inhibiting fusion between
autophagosomes and lysosomes. Collectively, these results indicate
that increased amounts of p62 in U2OS cells overexpressing SPBP
is due to enhanced expression of p62, and not inhibition or
impairment of the autophagy process. Moreover, siRNA mediated
depletion of SPBP in HeLa cells reproducibly reduced the
expression levels of LC3B I and reduced LC3B II formation
(Figure 5B and Figure S2B). This reduction was not due to the
decreased levels of p62, since siRNA mediated knock-down of p62
had no impact on the LC3B protein level (Figure 5B and Figure
S2B). All together, these results suggest that SPBP stimulates
autophagy activity by enhancing the expression levels of LC3B
and p62. We next raised the question whether SPBP itself could be
degraded by autophagy. SPBP is a nuclear protein, and hence
expected to be degraded by the proteasome. However, some
nuclear proteins are reported to translocate to the cytoplasm and
be involved in autophagy upon cellular stress, such as TP53INP1
[44], TP53INP2/DOR ([45,46]) and HMGB1 [47]. Immuno-
staining of endogenous SPBP and p62 in HeLa cells did not
indicate any co-localization of SPBP with p62 in p62 bodies
(Figure 5C, upper panel), not even upon sulforaphane treatment
for eight hours (Figure 5C, lower panel). Furthermore, immuno-
precipitation of SPBP from HeLa cell extracts did not co-
precipitate detectable amounts of p62 (data not shown). This
suggests that SPBP do not translocate to the cytoplasm upon
sulforaphane treatment. To further analyze whether SPBP could
be recruited to autophagosomes and degraded by autophagy, the
stability of SPBP was determined in HeLa cells which were amino
acid starved and treated with the autophagy inhibitor Bafilomycin
A1 or the proteasome inhibitor MG 132 for 4 hours. The results
presented in Figure 5D show that the amount of SPBP decreases
Figure 4. Nucleosome positioning sequences impair the synergistic effect of NRF2 and SPBP on the p62 promoter. Reporter
constructs (60 ng) containing the indicated nucleosome position sequences inserted downstream of the transcription start site of p62 promoter were
transfected into HEK293 cells together with the indicated amounts of expression plasmids for SPBP and/or NRF2. The luciferase activity of the
promoter constructs cotransfected with empty expression plasmids was set to 1. The data represent the mean of three independent experiments
with standard deviations, each performed in triplicate (***p,0.001, **p,0.01, *p,0.05).
doi:10.1371/journal.pone.0085262.g004
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when autophagy is inhibited, but not when the proteasome is
inhibited. This clearly indicate that SPBP is mainly degraded by
the proteasome.
SPBP acts as a coactivator of NRF2
Reporter gene assays using the wild type p62 promoter
indicated that coexpression of SPBP and NRF2 results in a
synergistic activation (Figure 6A). To further explore if SPBP may
act as a coactivator of NRF2, we analyzed whether the two
proteins colocalize in cells. SPBP is a chromatin binding protein
enriched in chromatin rich regions in the cell nucleus [31]. NRF2
is under normal conditions kept in the cytoplasm and directed to
degradation by interaction with the molecular sensor protein
KEAP1. Upon oxidative stress, NRF2 is released from KEAP1
and translocates to the nucleus where it can bind to ARE elements
and direct transcription of p62, phase II enzymes and other stress
induced proteins with ARE elements in their control regions
(reviewed in [48]). Coexpressed EGFP-NRF2 and Cherry-SPBP in
HeLa cells displayed nearly complete colocalization in the nucleus,
with a calculated Pearson’s correlations coefficient of around 0.95
for all cells in which they were coexpressed (Figure 6B). When
Cherry-SPBP was present, EGFP-NRF2 was recruited to the
nuclear speckles enriched for SPBP. In contrast, cells without
Cherry-SPBP expression displayed a diffuse nuclear EGFP-NRF2
staining (Figure 6B, lower panel, and Figure S2C). This indicates
that SPBP has the ability to recruit NRF2 to specific locations on
chromatin. However, immunoprecipitation experiments in HeLa
cells revealed that SPBP coprecipitate very weakly with NRF2
(Figure S2D), suggesting that their co-localization is dependent on
chromatin. Interestingly, Western Blots of NRF2 in HeLa cell
Figure 5. SPBP is not degraded by autophagy. (A) Over-expression of SPBP enhances the protein level of p62 in U2OS cells. Cell extracts of
U2OS cells stably over-expressing EGFP or EGFP-SPBP were exposed to western blotting using the indicated antibodies. The graph shows fold
induction calculated and correlated to actin in three independent experiments with standard deviations (*p,0.05, n.s. not significant). (B) siRNA
mediated knock-down of SPBP impairs LC3B expression. Cell extracts of HeLa cells transfected with SPBP siRNA, p62 siRNA or Control siRNA were
subjected to western blotting using the indicated antibodies. (C) Endogenous SPBP is not recruited to p62 bodies upon sulforaphane treatment.
HeLa cells were treated with DMSO (upper panel) or 20 mM sulforaphane for 8 hours (lower panel), fixed and stained with antibodies against SPBP
(green) and p62 (red). (D) SPBP is degraded by the proteasome. Extracts from HeLa cells starved in HBSS (2 hours), left untreated or treated with
Bafilomycin A1 (0.2 mM) or/and MG132 (0.2 mM) for 4 hours were subjected to western blot using the indicated antibodies. The graph shows the
average quantification of the expression levels of p62 and SPBP obtained in two independent experiments.
doi:10.1371/journal.pone.0085262.g005
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extracts treated with SPBP siRNA and sulforaphane showed that
the amount of NRF2 is significantly reduced when SPBP is
knocked down (Figure S2E). The KEAP1 expression level on the
other hand, is unaffected by SPBP siRNA treatment, indicating
that the reduced NRF2 expression is not due to enhanced
degradation mediated by KEAP1. Collectively, these results
suggest that SPBP acts as a coactivator of NRF2, promoting
expression of NRF2 and NRF2 target genes such as p62 and
LC3B under oxidative stress conditions mimicked by sulforaphane
treatment.
Discussion
Here we have shown that the expression of the transcriptional
coregulator SPBP is upregulated upon sulforaphane treatment of
cells, and that SPBP may be involved in the protection of cells
against oxidative stress since it acts as a coactivator of NRF2.
Interestingly, a recent genome wide siRNA screen showed that
SPBP (named TCF20 therein) was important for both Cyp1A1
and NQO1 expression upon cellular stress induced by 2,3,7,8-
tetrachlorodibenzo-p-dioxin [49]. Induction of NQO1 is previ-
ously shown to be completely dependent on the NRF2-ARE
pathway [50]. This clearly supports our results presented here, and
adds to an increasing amount of reports regarding stress-mediated
regulation of transcriptional coregulators and their impact on
stress-induced cellular processes. Many of these cofactors have the
ability to act as sensors for metabolic or oxidative changes within
the cells, inducing expression of genes involved in cell adaption to
the changed metabolic or oxidative conditions. Examples are; i)
the chromatin remodeling factor Pontin which is methylated in
hypoxic condition, resulting in strongly activation of a subset of
hypoxia target genes via HIF-1a [51], ii) the chromatin
remodeling factor Reptin, which also is methylated in hypoxic
conditions, and negatively regulate a subset of hypoxia-responsive
genes [52], iii) the level and enzymatic activity of the histone
metyltransferases and transcriptional regulators G9a, Suv39h and
PRMT2 which are shown to be regulated by hypoxia (reviewed in
[53]), and importantly, the expression levels of several members of
the transcriptional coregulator family JmjC (demethylases) which
are shown to be induced by hypoxia (reviewed in [53]). Their
enzymatic activity requires molecular oxygen, making them
perfect as oxygen sensors. In addition, expression of the Class
III histone deacetylase Sirt1 is induced by E2F1 phosphorylated by
the stress-responsive kinase ataxia telangiectasia mutated (ATM),
by p53 and FOXO3a (activated in nutrient-deprived mammalian
cells), by c-Myc and by the redox sensor carboxy terminal of E1A-
binding protein (CtBP) (reviewed in [54]). Expression of the
coactivator PGC-1a is induced by beta guanidinopropionic acid
(GPA) in striatum and cerebral cortex [55], while the transcription
coactivator Eya2 is shown to be upregulated during physiological
hypertrophy [56]. Hence, transcriptional coregulators are impor-
tant for cell adaption and protection against oxidative stress, and
especially for the prolonged cellular adaption since their impact
are mainly at the transcriptional level. SPBP is itself induced upon
sulforaphane treatment and thus may be important for the
prolonged upregulation of sulforaphane induced genes such as
NRF2, p62, LC3B, NQO1 and other phase II detoxification
enzymes.
It is well known that the transcription factor NRF2 regulates the
basal and inducible expression of a wide array of antioxidant genes
via AREs in their control regions (reviewed in [1,2,57]). We have
shown that NRF2 binds to a specific ARE element in the
autophagic receptor protein p62 promoter and increases its
expression level upon sulforaphane treatment of cells [25]. Here
we have shown that the coactivator SPBP enhances expression
from the p62 promoter via the ARE elements in its promoter
control region. siRNA mediated knock-down of SPBP significantly
reduced both the amount of p62 proteins and the number of p62
bodies in HeLa cells. Furthermore, we found that NRF2 and
SPBP act synergistically on the p62 promoter, and that knock-
down of SPBP significantly reduced the sulforaphane induced
expression of NRF2. Interestingly, it is reported that NRF2
contains two ARE-like elements in its own promoter and
Figure 6. SPBP and NRF2 cooperate to induce expression from the p62 promoter, and colocalize in nuclear speckles. (A) SPBP and
NRF2 cooperate to enhance expression from the wild type p62 promoter. Transient transfections were carried out in HEK293 cells using 60 ng of the
p62 promoter construct (21781/+46), and 50 ng or 100 ng of an NRF2 expression vector, and 100 ng of a SPBP expression vector, as indicated. The
data represent the mean of three independent experiments with standard deviations, each performed in triplicate (***p,0.001, *p,0.05). (B) SPBP
recruits NRF2 to specific nuclear speckles. HeLa cells were transiently transfected with expression vectors for EGFP-NRF2 and mCherry-SPBP, and
analysed 24 hours post transfection by live cell imaging using a confocal laser scanning fluorescence microscope. The Pearson’s colocalisation scatter
was generated using Volocity (Perkin Elmer).
doi:10.1371/journal.pone.0085262.g006
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autoregulate its own expression via the ARE-like element located
at position 2754 [58]. Furthermore, NRF2 is found to be
associated with its own promoter in genome wide chromatin
immunoprecipitation analyses (ENCODE project at www.
genome.gov). This suggests that SPBP may enhance NRF2
induction via the ARE elements in the NRF2 promoter, and
thereby strengthen both the magnitude and the duration of the
sulforaphane mediated enhancement of NRF2 expression – and
the magnitude and the duration of expression of proteins regulated
by NRF2 such as p62. From this we propose that SPBP may be a
player in the positive feedback loop established to enhance
expression of NRF2 and NRF2 regulated genes in response to
oxidative stress, contributing to the strength and duration of the
oxidative stress response. Additionally, we found that over-
expression of SPBP recruits NRF2 to specific nuclear speckles
previously identified as chromatin-rich regions [31]. This indicates
that SPBP may recruit NRF2 to specific regions on chromatin,
even if co-immunoprecipitation analysis indicated very weak
association between NRF2 and SPBP. The histone acetyltranse-
ferase MOZ is shown to act as a coactivator of NRF2-MafK.
MOZ was found to bind to MafK via its PHD domain [59]. This
suggests that SPBP may recruit NRF2 to chromatin via its ePHD/
ADD domain interacting with MafK. This should be addressed in
further studies.
Others have shown that the DNA binding activity of NRF2 is
modulated by the transcriptional coregulator CBP/p300 [34].
CBP/p300 directly acetylates lysine residues in the DNA binding
domain of NRF2 in response to arsenite-induced stress, resulting
in enhanced DNA binding and enhanced transcription of NRF2
regulated genes. Here we found that CBP clearly enhances
expression from the p62 promoter. However, the enhancement
seemed not to be dependent on the ARE elements in the
promoter. This suggests that CBP is able to mediate effect on the
p62 promoter at other sites than the two conserved ARE elements
mutated here.
We observed that depletion of SPBP impaired expression of
LC3B. Hence, SPBP may have impact on the autophagy process
by enhancing expression of LC3B, leading to increased formation
of LC3B II. Recent results presented by Fujita et al. [60], indicate
that siRNA mediated knock down of NRF2 significantly reduces
LC3B expression. Furthermore, sequence analysis of the LC3B
promoter predicts two putative NRF2 binding sites, one located
around position 2500 and one located further upstream around
position 21750. Interestingly, these locations of NRF2 binding
sites in the LC3B promoter are similar to the locations of the two
NRF2 binding sites in the p62 promoter. Thus, SPBP may
regulate LC3B expression via these NRF2 binding sites similarly as
we here have shown for the p62 promoter. An interesting question
to address for further study would therefore be whether SPBP
together with NRF2 is involved in stress-induced coregulation of
LC3B and p62, which both are important proteins in selective
autophagy.
So far, no enzymatic activity has been associated with SPBP,
and bioinformatic analyses do not predict any specific domains or
regions with similarity to enzyme activity. Hence, the mechanism
involved in SPBP induced enhancement of ARE containing
promoters is unclear. We have previously shown that SPBP binds
strongly to nucleosomes and is able to bind histones directly [31].
Nucleosomes pose a barrier to RNA polymerase II, and it has been
shown that some transcriptional coactivators enhance transcrip-
tion by facilitating RNA polymerase II traversal of nucleosomes
during transcriptional elongation [40]. Here we evaluated whether
SPBP had the ability to facilitate transcription when a nucleosome
forming sequence was inserted immediately downstream of the
transcription initiation site in the p62 and NQO1 promoters. We
found that the SPBP mediated transcriptional stimulation was
reduced when a nucleosome positioning sequence was present.
The NRF2 mediated induction of the p62 promoter was reduced
similarly. Importantly, coexpression of SPBP and NRF2 did not
result in synergistic stimulation of the p62 promoter constructs
with a positioned nucleosome sequence, indicating that SPBP do
not act on the p62 promoter by facilitating traversal of a
nucleosome structure. Similar results were obtained for the
NQO1 promoter, which strengthen the conclusion.
p62 is an autophagy receptor protein degraded by autophagy.
The observation that SPBP affected the expression level of p62
and the amount of p62 bodies in the cytoplasm, raised the question
whether SPBP is directly involved in regulation of the autophagy
machinery in the cell. The nuclear proteins HMGB1 [47],
TP53INP1 [44], and DOR/TP53INP2 [45,46] are reported to be
translocated to the cytoplasm upon cellular stress and participate
in regulation of autophagosome formation and protein degrada-
tion. However, we were not able to detect any nuclear
translocation of SPBP upon sulforaphane treatment of HeLa cells.
But, we found that SPBP has impact on the expression of proteins
directly involved in autophagy, such as LC3B and p62, and on
NRF2 that is involved in stress-induced expression of proteins
involved in autophagy. However, whether NRF2 inhibits or
stimulates the autophagy machinery is somehow contradictory in
the literature (see f. ex. [61–63]). Here, we see a correlative
upregulation of NRF2, p62, and SPBP within the first 12 hours of
sulforaphane treatment, peaking at 6 – 10 hours of treatment.
Another study has looked at protein expression levels after
24 hours or more with Mitoquinone treatment, and found that
NRF2 downregulates LC3B expression [63]. This may indicate
that as an immediate response to oxidative stress, NRF2 stimulates
the autophagy machinery, while it downregulates autophagy
activity in the prolonged response. To conclude, our data indicate
that SPBP, which itself is induced by oxidative stress, is important
for enhanced induction of proteins involved in the cellular
defensive program against oxidative stress, such as NRF2, and
the autophagy machinery here represented by p62 and LC3B.
Supporting Information
Figure S1 Nucleosome positioning sequences impair
the SPBP mediated enhancement of the p62 and NQO1
promoters. (A and B) Reporter constructs (60 ng) containing
the indicated nucleosome position sequences inserted downstream
of the transcription start site of p62 promoter (A) or NQO1
promoter (B) were transfected into HEK293 cells together with the
indicated amounts of expression plasmids for SPBP or NRF2. The
luciferase activity of the promoter constructs cotransfected with
empty expression plasmid was set to 1. The data represent the
mean of three independent experiments with standard deviations,
each performed in triplicate.
(TIF)
Figure S2 SPBP impacts on NRF2, p62 and LC3B
expression levels in HeLa and U2OS cells. (A) p62 seems
to be degraded normally by autophagy in the U2OS cells over-
expressing EGFP-SPBP. Cell extracts from U2OS cells overex-
pressing EGFP-SPBP or EGFP, and treated with DMSO or
Bafilomycin A1 (0.2 mM for 4 hours), were separated by SDS-
PAGE and blotted against the indicated antibodies. (B) Knock-
down of SPBP reduces the expression levels of NRF2, p62 and
LC3B in HeLa cells. Cell extracts of HeLa cells transfected with
the indicated siRNAs for 48 hours, and stimulated by sulforaph-
ane (20 mM) or DMSO for the last 8 hours, were separated by
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SDS-PAGE and blotted against the indicated antibodies. (C)
NRF2 is not recruited to specific nuclear speckles when
coexpressed with mCherry. HeLa cells were transiently transfected
with expression vectors for EGFP-NRF2 and mCherry, and
analysed 24 hours post transfection by live cell imaging using a
confocal laser scanning fluorescence microscope. Pearson’s
colocalisation scatter was generated using Volocity (Perkin Elmer).
(D) SPBP associates weakly with NRF2. HeLa cells were
transfected with expression vectors for EGFP-NRF2 and Myc-
SPBP, or EGFP and Myc-SPBP. EGFP-NRF2 was immunopre-
cipitated with GFP antibody 20 hours post transfection. Precip-
itated EGFP-NRF2 and co-precipitated SPBP were detected by
western blotting using the indicated antibodies. (E) siRNA
mediated knock-down of SPBP impairs sulforaphane induced
NRF2 expression. HeLa cells were transfected with SPBP siRNAs
or Control siRNA as indicated. Cells were treated with
sulforaphane for eight hours two days post transfection. The cell
extracts were subjected to western blot using the indicated
antibodies. The graph shows fold reduction calculated and
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